What Is Optic Neuritis? Symptoms, Causes & Treatment

Optic neuritis is inflammation of the optic nerve, the cable that carries visual information from your eye to your brain. The inflammation damages the protective myelin coating around the nerve fibers, disrupting signal transmission and causing vision loss, eye pain, and changes in color perception. It most commonly strikes adults between ages 20 and 40, and it can be an early sign of multiple sclerosis or other autoimmune conditions.

What Happens Inside the Optic Nerve

The optic nerve is wrapped in a myelin sheath, a fatty insulating layer that allows electrical signals to travel quickly and efficiently from retina to brain. In optic neuritis, immune cells (mainly T lymphocytes and macrophages) infiltrate the nerve and attack this myelin. The inflammatory process releases signaling molecules that accelerate the destruction, stripping away insulation and exposing the bare nerve fibers underneath.

Without intact myelin, nerve signals slow down, become garbled, or fail entirely. This is what produces the vision problems. In mild cases, signals still get through but less reliably. In severe cases, the nerve can barely transmit anything, and vision drops dramatically. The damage concentrates in the nerve’s white matter, and while much of it can heal over weeks to months, repeated episodes or severe inflammation can cause permanent injury to the nerve fibers themselves.

How It Feels: Pain and Vision Changes

Eye pain is the most recognizable early symptom. The landmark Optic Neuritis Treatment Trial (ONTT) found that 92% of patients reported pain in or around the affected eye, and 87% said the pain worsened when they moved their eyes. This happens because the inflamed optic nerve sits close to the muscles that control eye movement at the back of the eye socket. When those muscles contract, they tug against the swollen nerve sheath. Some people also experience headaches, particularly when the nerve sheath is severely inflamed.

Vision loss usually develops over hours to days. It can affect central vision, peripheral vision, or both, and the patterns vary. Scotomas (blind or dim spots) are the most common defect, but arc-shaped gaps and other irregular patterns also occur. Colors often look washed out or faded compared to the unaffected eye. Most people notice the problem in one eye, though bilateral involvement happens, especially in children.

What Causes It

The most common association is with multiple sclerosis. In MS, the immune system periodically attacks myelin throughout the central nervous system, and the optic nerve is a frequent target. For some people, optic neuritis is the very first MS symptom they experience, appearing before any other neurological signs.

Two other autoimmune conditions cause distinct forms of optic neuritis. Neuromyelitis optica spectrum disorder (NMOSD) involves antibodies against a water channel protein called aquaporin-4 found on brain cells. NMOSD-related optic neuritis tends to be more severe, with over 75% of patients losing vision to 20/200 or worse at the worst point. MOG antibody-associated disease (MOGAD) targets a different protein on the myelin surface and often causes visible swelling of the optic disc, sometimes with small hemorrhages around it.

Less commonly, infections like syphilis, cat-scratch disease, and certain viruses can trigger optic nerve inflammation. In some cases, no underlying cause is found, and the episode is classified as idiopathic.

How It’s Diagnosed

Diagnosis starts with a clinical exam: checking visual acuity, color vision, pupil responses, and visual fields. A key finding is a relative afferent pupillary defect, where the affected eye’s pupil doesn’t constrict as well when light is shone into it, because the damaged nerve isn’t transmitting the light signal properly.

MRI is the primary imaging tool. It can reveal the inflamed, swollen optic nerve using contrast-enhanced and specialized sequences. The length of the lesion on MRI matters: nerve enhancement stretching longer than about 17 mm correlates with worse initial visual acuity and contrast sensitivity. Longer lesions and more intense enhancement during the acute phase also predict poorer recovery at 12 months.

Optical coherence tomography (OCT) measures the thickness of nerve fiber layers at the back of the eye. Thinning of these layers typically becomes visible within the first three months after onset, with reductions averaging 15 to 18 micrometers. The pattern of thinning can help distinguish between MS-related, NMOSD-related, and MOGAD-related disease. In NMOSD, the loss tends to be abrupt and widespread across all sectors, while MS-related optic neuritis primarily thins the temporal (outer) portion.

Blood tests for aquaporin-4 and MOG antibodies help classify the type of optic neuritis. Cell-based assays for aquaporin-4 antibodies have a sensitivity of about 75% and specificity over 99%. MOG antibody testing is also highly specific at around 98%, though its positive predictive value drops at lower antibody levels. These distinctions matter because each condition has a different long-term outlook and treatment strategy.

Treatment and What to Expect

The standard acute treatment is high-dose corticosteroids, typically given intravenously over three days. The ONTT established this approach decades ago, and a more recent randomized trial found that a high-dose oral corticosteroid regimen can produce equivalent results. The goal of steroids is to shorten the duration of the attack. They speed up recovery but don’t appear to change where your vision ends up months later.

For NMOSD and MOGAD, treatment extends beyond corticosteroids. These conditions carry a higher risk of recurrence and more severe damage, so long-term immunosuppressive therapy is often recommended to prevent future attacks.

Vision Recovery

The prognosis for a first episode of typical optic neuritis is encouraging. In the ONTT, improvement began within the first month in nearly all patients regardless of which treatment group they were in. Among those who started with visual acuity of 20/50 or worse, every single patient improved by at least one line on the eye chart, and all but six improved by three or more lines over six months. Even people with severe initial vision loss generally recovered well.

The best predictor of your final visual outcome is how much vision you lost at the start. Older age was statistically linked to slightly worse results, but the difference was small enough to be clinically unimportant. If your vision isn’t following the typical recovery pattern, that’s a signal to investigate further for an atypical cause like NMOSD or MOGAD.

Long-Term Effects and Heat Sensitivity

Even after a good recovery, many people notice that their vision temporarily worsens when their body temperature rises. This is called the Uhthoff phenomenon, and it affects an estimated 60% to 80% of people with MS-related demyelination. A hot shower, exercise, a fever, or simply being outside on a warm day can trigger it.

The mechanism is remarkably sensitive. A body temperature increase of just 0.2°C to 0.5°C is enough to shut down electrical conduction in partially healed nerve fibers. Demyelinated nerves operate with a thinner margin of safety for transmitting signals. Heat causes voltage-gated sodium channels along those fibers to close prematurely, and the signal simply stops getting through. Vision blurs, dims, or develops blind spots that mirror the original attack. The effect reverses once body temperature returns to normal, usually within minutes to hours, and it does not represent new damage to the nerve.

Optic Neuritis in Children

Children present differently from adults in one important way: bilateral involvement is far more common. A study reviewed by the American Academy of Ophthalmology found that 49% of pediatric cases affected both eyes. The younger the child, the more likely both eyes are involved: 72% of children under age 10 had bilateral disease compared to 30% of adolescents. In children with both eyes affected, detecting the relative pupillary defect is harder since both nerves are compromised, though it’s still found in about 47% of bilateral cases.

Pediatric optic neuritis also has a different relationship with MS than the adult form. A larger proportion of childhood cases are linked to MOGAD, and the visual prognosis in children is generally favorable, though recurrent episodes can occur.